ArticleCureus2025
Long-Term Management of Sympathetic Ophthalmia Developing in the Early Period Following Trauma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report presents a rare instance of sympathetic ophthalmia (SO) in a patient who developed globe rupture due to blunt ocular trauma. It provides insights into the clinical course and three-year follow-up of successful treatment achieved through systemic immunosuppressive therapy. A 45-year-old male patient sustained blunt trauma to his left eye. Due to clinical signs indicative of rupture, conjunctival exploration was performed, revealing a scleral rupture that was primarily repaired. On postoperative day 18, the patient developed bilateral panuveitis consistent with trauma-induced SO. Diagnosis was supported by clinical signs, optical coherence tomography (OCT), and fundus fluorescein angiography (FFA). Treatment included systemic corticosteroids and immunosuppressive agents (cyclosporine and azathioprine), with dose adjustments during follow-up. Three years later, following cataract surgery, visual acuity in the injured eye improved to 0.7 (Snellen). OCT and FFA findings normalized, and systemic therapy was well tolerated except for mild gingival hyperplasia attributed to cyclosporine. This case underscores the importance of early diagnosis and aggressive immunosuppressive therapy in managing early-onset SO following globe rupture. Long-term follow-up demonstrated effective inflammation control and stable visual acuity, supporting the efficacy of combined immunosuppressive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.